BANNOCKBURN, Ill.--(BUSINESS WIRE)--The Board of Directors of Baxalta Incorporated (NYSE: BXLT) today declared a quarterly cash dividend of $0.07 per share of common stock. The quarterly dividend will be paid on April 1, 2016, to stockholders of record as of the close of business on March 10, 2016.
About Baxalta
Baxalta Incorporated (NYSE: BXLT) is a global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, immunology and oncology.
